EP3279195

SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    30.11.2009
  • EP published:
    1.7.2020
  • EP application number:
    17179369.8
  • Max expiry date:
    29.11.2029
  • Title:
    SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE

Timeline

Today
30.11.2009EP application
1.7.2020EP Publication

Owner

  • Name:
    Oyster Point Pharma, Inc.
  • Address:
    202 Carnegie Center, Suite 109, Princeton, New Jersey 08540, US

Inventor

  • Name:
    Akireddy, Srinivisa Rao
  • Address:
    Winston-Salem, NC 27104, US
  • Name:
    Bhatti, Balwinder Singh
  • Address:
    Winston-Salem, NC 27106, US
  • Name:
    Cuthbertson, Timothy J.
  • Address:
    Winston-Salem, NC 27106, US
  • Name:
    Dull, Gary Maurice
  • Address:
    Lewisville, NC 27023, US
  • Name:
    Miller, Craig, Harrison
  • Address:
    Winston-Salem, NC 27103, US
  • Name:
    Mitchener, JR., Joseph Pike
  • Address:
    Winston-Salem, NC 27106, US
  • Name:
    Munoz, Julio A.
  • Address:
    Walnut Cove, NC 27052, US
  • Name:
    Otten, Pieter Albert
  • Address:
    King, NC 27021, US

Priority

  • Number:
    118796 P
  • Date:
    1.12.2008
  • Country:
    US

Classification

  • Categories:
    C07D 403/06, A61K 31/505, A61P 25/00

Upload documents